This case demonstrates that facial malformations can be found in patients with RAPSN-associated CMS due to variants outside of the promoter region, thus expanding the genotypic spectrum of facial malformations in RAPSN-associated CMS. This evidence concerns the gene RAPSN and congenital myasthenic syndrome.